
MIOLive 2026
January 26 – January 27
Rome, Italy
IASIOS is pleased to participate in MIOLive 2026 in Rome. This year’s programme includes a joint MIOLive meets CIRSE/NEXT RESEARCH/IASIOS Session, highlighting key developments in education, professional support, clinical evidence generation, and quality assurance in interventional oncology.
Join us for a focused 30-minute session that brings together multiple perspectives on how structured support, accreditation, and research frameworks are advancing interventional oncology across Europe and internationally.
Session Information:
- Title: MIOLive meets CIRSE/NEXT RESEARCH/IASIOS Session
- Date: Monday, January 26
- Time: 10:15 -10:45
Moderators:
- Prof. Tiago Bilhim – Unidade Local de Saúde de São José, IASIOS Accredited Centre
- Prof. Laura Crocetti – Azienda Ospedaliero Universitaria Pisana, IASIOS Accredited Centre
- Prof. Roberto Iezzi – Fondazione Policlinico A. Gemelli, IASIOS Accredited Centre
Presentations and Speakers:
• Shaping the future, Overview of the European Situation for Early-Career Interventional Radiologists – Prof. Philippe Pereira
• CIRSE benefits for interventional radiologists – Mr. Daniel Waigl
• Advancing Quality, Safety, and Recognition in IO with IASIOS – Ms. Mardis Karlsdottir
• Clinical evidence generation in IO supported by NEXT Research – Ms. Nathalie Kaufmann
This session offers insight into the evolving landscape of interventional oncology, with a particular focus on how structured pathways such as IASIOS accreditation, CIRSE support initiatives, and evidence generation through NEXT Research are strengthening clinical practice and professional development.
Explore the full MIOLive 2026 programme to discover additional sessions, live case discussions, and activities highlighting the latest advancements in interventional oncology and minimally invasive cancer therapies.
Get ahead:
Interested in learning how your facility compares to the criteria for IASIOS accreditation?
Complete our self-assessment online to evaluate how your facility currently aligns with the IASIOS standards. Our team member will be at the MIOLive 2025 to discuss your results and guide you through the next steps towards becoming an IASIOS Accredited Centre
Hear from other facilities:
Learn how the IASIOS accreditation has made a difference for interventional oncology facilities worldwide. Read testimonials from our accredited members and discover how IASIOS can help your practice achieve new levels of excellence in patient care.